Elsevier launches open access journal, Pathogenesis

NewsGuard 100/100 Score

Elsevier, world-leading provider of scientific, technical and medical information products and services, announces the launch of open access journal, Pathogenesis.

Pathogenesis will be published on behalf of The Royal College of Pathologists a professional membership organization committed to setting and maintaining professional standards and promoting excellence in the practice of Pathology. The College represents 19 pathology specialties and has over 10,000 members working in hospital laboratories, universities and industry, worldwide.

Pathogenesis will provide a home for research covering all areas of illness and normal cellular and molecular development in human and veterinary disease. The journal Pathogenesis will publish peer reviewed original scientific research articles and high quality reviews, editorials and letters to the editor which report on multidisciplinary areas of Molecular and Diagnostic Pathology, Cellular Mechanisms as well as aspects of Haematology, Proteomics, Virology, Microbiology and Chemical Pathology.

The Editor-in-Chief of the journal, Professor Finbarr Cotter, Barts Cancer Institute, Queen Mary University of London, UK said of the launch, "This is a tremendous cooperation between The Royal College of Pathologists and Elsevier, one which confirms the major commitment by the College towards the modernization of the field of pathology with both academic and molecular pathology leading the way."

Professor Cotter will work closely with Section Editors: Professor Ian Cree University Hospital Coventry and Warwickshire, UK and Dr George Vassilou, Wellcome Trust Sanger Institute, Cambridge, UK.

"We are delighted to announce the launch of this new open access journal. We look forward to working together with the journal editors and The Royal College of Pathologists offering their members, researchers and clinicians a platform through which they can publish their research quickly and make it widely available," said Rachel Garland, Publisher at Elsevier.

Source: Queen Mary University

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer